Compare NDLS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NDLS | DRIO |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 60.6M |
| IPO Year | 2013 | 2013 |
| Metric | NDLS | DRIO |
|---|---|---|
| Price | $13.75 | $7.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 28.8K | 6.9K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $495,089,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $6.02 |
| Revenue Growth | 0.37 | ★ 43.02 |
| 52 Week Low | $0.47 | $0.38 |
| 52 Week High | $13.95 | $17.74 |
| Indicator | NDLS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 63.74 | 44.48 |
| Support Level | $0.59 | $7.29 |
| Resistance Level | $13.95 | $9.46 |
| Average True Range (ATR) | 1.02 | 0.42 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 90.15 | 46.09 |
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.